相似文献
1
South Africa responds to new SARS-CoV-2 variant.
Lancet. 2021 Jan 23;397(10271):267. doi: 10.1016/S0140-6736(21)00144-6.
2
Audio Interview: Covid-19 in South Africa and a New SARS-CoV-2 Variant.
N Engl J Med. 2021 Jan 14;384(2):e14. doi: 10.1056/NEJMe2100736.
3
Novavax offers first evidence that COVID vaccines protect people against variants.
Nature. 2021 Feb;590(7844):17. doi: 10.1038/d41586-021-00268-9.
4
Heavily mutated Omicron variant puts scientists on alert.
Nature. 2021 Dec;600(7887):21. doi: 10.1038/d41586-021-03552-w.
5
Audio Interview: The Omicron Variant of SARS-CoV-2.
N Engl J Med. 2021 Dec 2;385(23):e96. doi: 10.1056/NEJMe2118839.
6
Audio Interview: The Real-World Effectiveness of Covid-19 Vaccination.
N Engl J Med. 2021 Feb 25;384(8):e40. doi: 10.1056/NEJMe2103272.
7
The world needs a single naming system for coronavirus variants.
Nature. 2021 Jan;589(7842):330. doi: 10.1038/d41586-021-00105-z.
8
COVID-19 and the Swedish enigma.
Lancet. 2021 Jan 23;397(10271):259-261. doi: 10.1016/S0140-6736(20)32750-1. Epub 2020 Dec 23.
9
The race for a COVID-19 vaccine.
Can J Dent Hyg. 2020 Oct 1;54(3):107-109.
10
How severe are Omicron infections?
Nature. 2021 Dec;600(7890):577-578. doi: 10.1038/d41586-021-03794-8.
引用本文的文献
1
Passive infusion of an S2-Stem broadly neutralizing antibody protects against SARS-CoV-2 infection and lower airway inflammation in rhesus macaques.
PLoS Pathog. 2025 Jan 23;21(1):e1012456. doi: 10.1371/journal.ppat.1012456. eCollection 2025 Jan.
2
Passive infusion of an S2-Stem broadly neutralizing antibody protects against SARS-CoV-2 infection and lower airway inflammation in rhesus macaques.
bioRxiv. 2024 Jul 30:2024.07.30.605768. doi: 10.1101/2024.07.30.605768.
3
Genomic surveillance and serological profile of SARS-CoV-2 variants circulating in Macaé and nearby cities, southeastern Brazil.
Front Microbiol. 2024 Apr 30;15:1386271. doi: 10.3389/fmicb.2024.1386271. eCollection 2024.
4
Advances and Challenges in SARS-CoV-2 Detection: A Review of Molecular and Serological Technologies.
Diagnostics (Basel). 2024 Feb 29;14(5):519. doi: 10.3390/diagnostics14050519.
5
Inducing enhanced neutralizing antibodies against broad SARS-CoV-2 variants through glycan-shielding multiple non-neutralizing epitopes of RBD.
Front Immunol. 2023 Dec 11;14:1259386. doi: 10.3389/fimmu.2023.1259386. eCollection 2023.
6
From past to present: Exploring COVID-19 in Qatar's hemodialysis population across Omicron dominant and pre-Omicron periods.
PLoS One. 2023 Sep 14;18(9):e0291266. doi: 10.1371/journal.pone.0291266. eCollection 2023.
7
Multi-scale risk assessment and mitigations comparison for COVID-19 in urban public transport: A combined field measurement and modeling approach.
Build Environ. 2023 Aug 15;242:110489. doi: 10.1016/j.buildenv.2023.110489. Epub 2023 Jun 2.
8
Development of a universal real-time RT-PCR assay for detection of pan-SARS-coronaviruses with an RNA-based internal control.
Front Microbiol. 2023 May 18;14:1181097. doi: 10.3389/fmicb.2023.1181097. eCollection 2023.
9
Clinical and laboratory features of SARS-CoV-2 variants across multiple rounds of pandemic waves in hospitalized children in an Iranian referral hospital.
BMC Pediatr. 2023 May 16;23(1):241. doi: 10.1186/s12887-023-04042-w.
10
Comprehensive structural analysis reveals broad-spectrum neutralizing antibodies against SARS-CoV-2 Omicron variants.
Cell Discov. 2023 Apr 4;9(1):37. doi: 10.1038/s41421-023-00535-1.
Zotero 插件